相关实验视频

Updated: Jun 26, 2025

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

[如何进行自身免疫和周围神经和肌肉的炎症性疾病的自身抗体检测]

Michiaki Koga¹

¹Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine.

Brain and nerve = Shinkei kenkyu no shinpo

|May 14, 2024

概括

自动抗体检测对于诊断神经和肌肉疾病至关重要. 了解测试准确性,临床相关性和保险覆盖率对于有效的患者管理至关重要.

科学领域:

神经学神经学
免疫学免疫学免疫学
临床诊断临床诊断临床诊断

背景情况:

自动抗体测量对于管理外围神经和肌肉疾病至关重要.
自体抗体测试的临床实用性在不同抗体之间有很大差异.
准确的解释需要了解测试准确性,同型分布和疾病活动相关性.

研究的目的:

强调在神经肌肉疾病中自抗体检测的重要性.
强调临床医生解释自身抗体测试结果的复杂性和考虑因素.
为了应对有限的医疗资源和保险覆盖所带来的挑战.

主要方法:

关于神经和肌肉疾病中自身抗体测试的当前文献的综述.
分析影响自身抗体测试临床意义的因素.
对临床医生进行实际考虑的讨论.

主要成果:

临床意义是抗体特异性的.
测试准确性,同型,子类和疾病活性是关键的解释因素.
许多测试缺乏保险覆盖,影响了资源分配.

结论:

临床医生需要全面的知识来正确解释自身抗体测试.
保持最新的诊断进展对于神经肌肉疾病的最佳患者护理至关重要.
有效利用自身抗体检测需要对临床背景和资源限制的认识.

更多相关视频

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood

Published on: January 9, 2018

相关概念视频

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...